Insider Transactions Reported by 23 Insiders of RECURSION PHARMACEUTICALS, INC.

Symbol
RXRX on Nasdaq
Location
Salt Lake City, UT

Insiders trading volume in the past year

RECURSION PHARMACEUTICALS, INC. executives and other stock owners filed with the SEC include:

Name Relationship Holdings Value Past Year Net Change Change % Report Date
Lux Ventures IV, L.P. Former 10% Owner $137,710,376 07 Dec 2021
Mubadala Investment Co PJSC 10%+ Owner $137,333,970 02 Mar 2023
Zachary Bogue Director, 10%+ Owner $39,514,048 03 Jul 2023
Blake Borgeson Director $28,993,402 -$1,920,600 -6.2% 06 Jan 2026
MIC Capital Partners (Public) Parallel Cayman, LP 10%+ Owner $14,688,335 01 Nov 2021
Dean Y. Li Director $13,174,278 02 Jan 2026
Michael Secora Chief Financial Officer $9,186,510 15 Nov 2024
Christopher Gibson Director $3,737,784 -$8,190,951 -69% 05 Jan 2026
Ben R. Taylor Chief Financial Officer $3,390,099 -$89,381 -2.6% 29 Dec 2025
Tina Marriott President and COO $3,129,811 15 Nov 2024
Najat Khan Chief R&D Commercial Officer, Director $2,694,983 -$750,765 -22% 22 Dec 2025
Shafique Virani Chief Business Officer $1,446,192 16 Jan 2024
David J. Mauro Chief Medical Officer $1,392,024 15 Nov 2024
Ramona Doyle Chief Medical Officer $1,280,811 16 May 2022
Zavain Dar Director $582,154 02 Jan 2026
Franziska Michor Director $573,009 18 Jun 2025
CHAVEZ R. MARTIN Director $529,780 01 Apr 2024
Terry-Ann Burrell Director $514,098 01 Jul 2024
ROBERT HERSHBERG Director $332,531 18 Jun 2025
Namandje Bumpus Director $214,482 18 Jun 2025
Elaine D. Sun Director $214,482 18 Jun 2025
David Hallett Cso $116,376 01 Jan 2026
MIC CAPITAL PARTNERS (PUBLIC) (US) IM, LLC Other* 01 Nov 2021

Recent Insider Transactions by Companies or Individuals for RECURSION PHARMACEUTICALS, INC.

Insider Symbol Class Transaction % Value $ * Price $ Shares Shares Owned Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.